Khondrion is a clinical-stage pharmaceutical company.
Khondrion has raised $5.7M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Khondrion's investors include EISMEA, Netherlands Enterprise Agency, Mito Fund.
Khondrion is headquartered in Nijmegen, The Netherlands.
Khondrion is a clinical-stage pharmaceutical company.
Khondrion is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Khondrion — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/khondrion. Accessed September 14, 2026.
VCBacked. (2025). Khondrion — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/khondrion
{{cite web |title=Khondrion — Funding & Investors |url=https://www.vcbacked.co/company/khondrion |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated